Colon-Specific Drug Delivery Based on a Cyclodextrin Prodrug: Release Behavior of Biphenylylacetic Acid from Its Cyclodextrin Conjugates in Rat Intestinal Tracts after Oral Administration
The DOI matches its Crossref record.
Abstract
An antiinflammatory drug biphenylylacetic acid (BPAA) as a model drug was selectively conjugated onto one of the primary hydroxyl groups of alpha-, beta-, and gamma-cyclodextrins (CyDs) through an ester or amide linkage, and the in vivo drug release behavior of these prodrugs in rat gastrointestinal tracts after oral administration was investigated. The CyD prodrugs were stable in rat stomach and small intestine and negligibly absorbed from these tracts. Three to six hours after the oral administration, most of the prodrugs had moved to the cecum and colon. The alpha- and gamma-CyD amide prodrugs were hydrolyzed to the maltose conjugate in the cecum and colon, and these prodrugs and the conjugate were negligibly absorbed. On the other hand, the alpha- and gamma-CyD ester prodrugs produced BPAA in the cecum and colon, and BPAA appeared in the blood after 3-6 h. Both beta-CyD amide and ester prodrugs released only small or negligible amounts of the maltose conjugate or BPAA in the cecum and colon, within 24 h, probably due to the low solubility in the biological media. Further, the antiinflammatory effect of the gamma-CyD ester prodrug was evaluated using the model of carageenan-induced acute edema in rat paw and compared with those of BPAA alone and the BPAA/beta-CyD complex prepared by the kneading method in a molar ratio of 1:1. In the case of the beta-CyD complex, a rapid antiinflammatory response was observed, compared to BPAA alone, because the drug is mainly absorbed from the small intestine after a fast dissolution of the complex. In sharp contrast, the gamma-CyD ester prodrug needed a fairly long lag time to exhibit the drug activity, because BPAA is produced after the prodrug had reached the cecum and colon. The present results clearly suggest that the CyD prodrug approach can provide a versatile means for constructions of not only colon-specific delivery systems but also delayed-release system of certain drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Polysaccharides in colon-specific drug delivery
Sinha, V. R., & Kumria, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00720-7 · Cited by 872
Cyclodextrin-based controlled drug release system
Hirayama, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00058-1 · Cited by 494
Self-citationCyclodextrins as Drug Carrier Molecule: A Review
Rasheed, A. (2008) · Scientia Pharmaceutica · doi:10.3797/scipharm.0808-05 · Cited by 394
Polysaccharides for Colon Targeted Drug Delivery
Chourasia, M. K., & Jain, S. K. (2004) · Drug Delivery · doi:10.1080/10717540490280778 · Cited by 349
Microbially triggered drug delivery to the colon
Sinha, V. R., & Kumria, R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00221-x · Cited by 316
Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems
Bibby, D. C., Davies, N. M., & Tucker, I. G. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00335-5 · Cited by 298
Kotla, N. G., Rana, S., Sivaraman, G., Sunnapu, O., Vemula, P. K., Pandit, A., & Rochev, Y. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.021 · Cited by 242
Arima, H., Kihara, F., Hirayama, F., & Uekama, K. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000111n · Cited by 222
Self-citationÜnal, S., Can Öztürk, S., Bilgiç, E., Yanık, H., Korkusuz, P., Aktaş, Y., Benito, J. M., Esendağlı, G., & Bilensoy, E. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.10.010 · Cited by 25
Metadata
- Authors
- Minami, K., Hirayama, F., & Uekama, K.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- American Geophysical Union (AGU)
- Published
- 1998-06
- Volume
- 87
- Issue
- 6
- Pages
- 715-720
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2066685337
- Cited by
- 91
- References
- 0
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.